Early initiation of ambroxol treatment diminishes neurological manifestations of type 3 Gaucher disease: A long-term outcome of two siblings-Reference-Cited by-同舟云学术

Early initiation of ambroxol treatment diminishes neurological manifestations of type 3 Gaucher disease: A long-term outcome of two siblings

Published:2021-05 Issue: Volume:32 Page:66-72
ISSN:1090-3798
Container-title:European Journal of Paediatric Neurology
language:en
Short-container-title:European Journal of Paediatric Neurology

Author:

Ramadža Danijela Petković,Zekušić Marija,Žigman Tamara,Škaričić Ana,Bogdanić Ana,Mustać Gordana,Bošnjak-Nađ Katarina,Ozretić David,Ohno Kousaku,Fumić Ksenija,Barić Ivo

Publisher

Elsevier BV

Subject

Neurology (clinical),General Medicine,Pediatrics, Perinatology and Child Health

Reference29 articles.

1. Gaucher disease: the metabolic defect, pathophysiology, phenotypes and natural history;Baris;Pediatr. Endocrinol. Rev.,2014

2. Gaucher disease: complexity in a "simple" disorder;Sidranski;Mol. Genet. Metabol.,2014

3. Neuronopathic gaucher disease: demographic and clinical features of 131 patients enrolled in the international collaborative gaucher group neurological outcomes subregistry;Tylki-Szymańska;J. Inherit. Metab. Dis.,2010

4. Phenotypic continuum in neuronopathic Gaucher disease: an intermediate phenotype between type 2 and type 3;Goker-Alpan;J. Pediatr.,2003

5. The spectrum of neurological manifestations associated with Gaucher disease;Roshan Lal;Diseases,2017

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and preclinical insights into high-dose ambroxol therapy for Gaucher disease type 2 and 3: A comprehensive systematic review;Molecular Genetics and Metabolism;2024-09

2. Molecular mechanisms of the ambroxol action in Gaucher disease and GBA1 mutation-associated Parkinson disease;Neurochemistry International;2024-09

3. Electroencephalogram and phenotype patterns in neuronopathic Gaucher disease patients – ten years of experience in a single center;Acta Epileptologica;2024-09-01

4. Hematopoietic stem cell transplantation or enzyme replacement therapy in Gaucher disease type 3;Molecular Genetics and Metabolism;2024-08

5. GBA1-Associated Parkinson’s Disease Is a Distinct Entity;International Journal of Molecular Sciences;2024-06-28